Halozyme Therapeutics, Inc. (HALO)
103.02
-0.61
(-0.59%)
USD |
NASDAQ |
Nov 09, 16:00
103.02
0.00 (0.00%)
After-Hours: 18:02
Halozyme Therapeutics Gross Profit (Annual) : 1.091B for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.091B |
| December 31, 2024 | 784.86M |
| December 31, 2023 | 563.12M |
| December 31, 2022 | 477.66M |
| December 31, 2021 | 361.90M |
| December 31, 2020 | 224.23M |
| December 31, 2019 | 150.45M |
| December 31, 2018 | 141.73M |
| December 31, 2017 | 285.46M |
| December 31, 2016 | 113.48M |
| December 31, 2015 | 105.81M |
| December 31, 2014 | 52.60M |
| December 31, 2013 | 48.55M |
| Date | Value |
|---|---|
| December 31, 2012 | 40.15M |
| December 31, 2011 | 54.73M |
| December 31, 2010 | 11.13M |
| December 31, 2009 | 11.92M |
| December 31, 2008 | 7.384M |
| December 31, 2007 | 2.983M |
| December 31, 2006 | 0.3008M |
| December 31, 2005 | -0.1311M |
| December 31, 2004 | 0.00 |
| December 31, 2003 | -0.0013M |
| December 31, 2002 | 0.0381M |
| December 31, 2001 | 0.0088M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| AVITA Medical, Inc. | 58.82M |
| Iovance Biotherapeutics, Inc. | 54.38M |
| Merck & Co., Inc. | 46.73B |
| Neurocrine Biosciences, Inc. | 2.808B |
| TG Therapeutics, Inc. | 515.57M |